Clinical Trials

Showing trials with last updates posted in 2025.

NCT07214909 | COMPLETED | NA
70 participants

Gastric POCUS Clear Liquids

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-09
Start Date:
2023-01-18
Completion:
2024-12-09
Conditions
  • Gastric Emptying Time
Interventions
  • OTHER
No Results Yet
NCT07214883 | RECRUITING
20000 participants

UCF MammoChat: Image Repository

Study Type:
OBSERVATIONAL
Last Updated:
2025-10-09
Start Date:
2025-09-03
Completion:
2026-06-30
Conditions
  • Breast Cancer
  • Breast Cancer Awareness
  • Breast Cancer Detection
  • Breast Cancer Survivors
  • Breast Cancer Female
  • Breast Cancer Diagnosis
Interventions
  • OTHER
No Results Yet
NCT07214649 | NOT_YET_RECRUITING | PHASE2
25 participants

Organoids for Bile Leaks

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-09
Start Date:
2026-01-31
Completion:
2030-06-30
Conditions
  • Biliary Anastomosis Complication
Interventions
  • BIOLOGICAL
No Results Yet
NCT07214441 | ENROLLING_BY_INVITATION | NA
20 participants

Evaluating the Feasibility and Preliminary Effects of BE+

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-09
Start Date:
2025-08-15
Completion:
2026-05-31
Conditions
  • Lung Cancer (Non-Small Cell)
  • Self-management Behavior
  • Physical Activity
  • Stress
  • Quality of Life
  • Resistance Training
Interventions
  • BEHAVIORAL
No Results Yet
NCT07214337 | NOT_YET_RECRUITING | NA
20 participants

Digital Inhaler Use in Obstructive Lung Disease Care

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-09
Start Date:
2025-11-01
Completion:
2027-01-31
Conditions
  • Chronic Obstructive Airways Disease Exacerbated
  • Chronic Obstructive Airway Disease
Interventions
  • DEVICE
No Results Yet
NCT07214051 | COMPLETED | NA
500 participants

PR-CEAL: Community Outreach Engagement Group

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-09
Start Date:
2023-12-13
Completion:
2024-07-12
Conditions
  • Breast Cancer Prevention
  • Colorectal Cancer Prevention
  • Cervical Cancer Prevention
Interventions
  • BEHAVIORAL
No Results Yet
NCT07213882 | NOT_YET_RECRUITING | EARLY_PHASE1
30 participants

A Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL)

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-09
Start Date:
2026-01-01
Completion:
2028-08-01
Conditions
  • Cutaneous T Cell Lymphoma (CTCL)
  • Mycosis Fungoides
  • Sezary Syndrome
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page